Six-Month Outcomes of Ahmed Glaucoma Valve Implantation Using a Patch Graft-Free Scleral Tunnel Technique in Eyes with Refractory Glaucoma: A prospective, non-comparative interventional study.
Thi Uyen Duyen Nguyen, Kim Thanh Doan, Bao Giang Kim
✦ AI-curated · Sources linked
In 30 seconds
This prospective, non-comparative interventional case series assessed six-month outcomes of Ahmed FP7 valve implantation using a patch graft-free scleral tunnel technique in 35 eyes of 35 patients with refractory glaucoma. Mean intraocular pressure fell from 33.54 ± 9.28 mmHg before surgery to 16.33 ± 5.00 mmHg at six months, a mean reduction of 49.3%. Overall success was 91.4%, comprising 40.0% complete and 51.4% qualified success. No tube exposure was observed.
Key findings
- Mean intraocular pressure decreased from 33.54 ± 9.28 mmHg preoperatively to 16.33 ± 5.00 mmHg at six months (p < 0.001), a 49.3% mean reduction.
- Mean glaucoma medication use fell from 3.80 ± 0.41 to 1.09 ± 1.09 at six months (p < 0.001).
- Overall success was 91.4%: 40.0% complete success and 51.4% qualified success.
- No tube exposure was observed during the six-month assessment.
Why it matters
The findings suggest that a scleral tunnel approach without a patch graft can provide substantial short-term pressure reduction and reduce medication burden in eyes with refractory glaucoma. The absence of observed tube exposure is relevant to a key postoperative concern, although the study’s design and follow-up do not establish comparative safety or longer-term durability.
What to keep in mind
The study was a non-comparative case series of 35 eyes, with outcomes assessed only through six months; it cannot establish comparative effectiveness or longer-term outcomes.